Creative Planning Alkermes Plc. Transaction History

Creative Planning

$103 Billion
Q4 2024

A detailed history of Creative Planning transactions in Alkermes Plc. stock. As of the latest transaction made, Creative Planning holds 71,452 shares of ALKS stock, worth $2.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,452

Previous 50,629 41.13%

Holding current value

$2.57 Million

Previous $1.42 Million 44.95%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $535,151 - $655,091	20,823 Added 41.13%	71,452 $2.05 Million
Q3 2024 Oct 11, 2024	BUY	$23.01 - $28.55 $397,244 - $492,887	17,264 Added 51.74%	50,629 $1.42 Million
Q2 2024 Aug 15, 2024	BUY	$23.21 - $27.24 $169,340 - $198,743	7,296 Added 27.99%	33,365 $804,000
Q1 2024 May 10, 2024	BUY	$26.4 - $32.56 $360,940 - $445,160	13,672 Added 110.28%	26,069 $705,000
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $55,480 - $68,086	2,374 Added 23.69%	12,397 $343,000
Q3 2023 Nov 16, 2023	BUY	$27.17 - $31.97 $61,567 - $72,444	2,266 Added 29.21%	10,023 $280,000
Q2 2023 Jul 21, 2023	BUY	$28.34 - $33.63 $219,833 - $260,867	7,757 New	7,757 $242,000
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $2,640 - $3,054	-100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $2,307 - $2,799	100 New	100 $3,000
Q2 2021 Aug 04, 2021	SELL	$18.78 - $25.15 $258,863 - $346,667	-13,784 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$18.21 - $23.2 $9,105 - $11,600	-500 Reduced 3.5%	13,784 $257,000
Q4 2020 Jan 29, 2021	SELL	$15.39 - $22.1 $38,475 - $55,250	-2,500 Reduced 14.9%	14,284 $285,000
Q2 2020 Jul 23, 2020	SELL	$13.31 - $19.41 $266 - $388	-20 Reduced 0.12%	16,784 $326,000
Q1 2020 May 05, 2020	SELL	$13.06 - $21.24 $27,582 - $44,858	-2,112 Reduced 11.17%	16,804 $242,000
Q4 2019 Jan 30, 2020	BUY	$17.29 - $21.74 $7,071 - $8,891	409 Added 2.21%	18,916 $386,000
Q2 2019 Jul 26, 2019	SELL	$21.47 - $37.33 $322 - $559	-15 Reduced 0.08%	18,507 $417,000
Q1 2019 Apr 24, 2019	SELL	$28.4 - $36.49 $11,502 - $14,778	-405 Reduced 2.14%	18,522 $676,000
Q4 2018 Feb 01, 2019	BUY	$27.94 - $44.61 $698 - $1,115	25 Added 0.13%	18,927 $559,000
Q3 2018 Oct 25, 2018	SELL	$38.6 - $46.12 $4,554 - $5,442	-118 Reduced 0.62%	18,902 $802,000
Q2 2018 Jul 20, 2018	BUY	$40.56 - $51.36 $27,621 - $34,976	681 Added 3.71%	19,020 $783,000
Q1 2018 Apr 18, 2018	BUY	$53.61 - $67.26 $10,614 - $13,317	198 Added 1.09%	18,339 $1.06 Million
Q4 2017 Jan 17, 2018	BUY	$47.69 - $55.39 $12,590 - $14,622	264 Added 1.48%	18,141 $993,000
Q3 2017 Oct 17, 2017	BUY	$49.16 - $54.45 $878,833 - $973,402	17,877	17,877 $909,000

Others Institutions Holding ALKS

# of Institutions

374

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Alkermes Plc. Transaction History